at APS ID19 synchrotron source using remote server. A rigorous screening (crystallization, cryo-preservation, and data collection) of several hundred crystals, yielded a few crystals with diffraction data to ~4.5 Å resolution. The diffraction data indicated space group P21 with unit cell: a=174. 51, b=186.94, c=275.83 Å and =98.84 degree. Combined diffraction data sets of 4.5Å resolution from three crystals were scaled by using HKL2000. The data statistics are included in Supplemental Table 1 .
These data suggested the presence of about 12 IKK1 monomers in the asymmetric unit even with assumption of the solvent content of the crystal to be 70%.
X-Ray Structure Determination:
Due to the low resolution of the data, variable conformation of search models, and multiple molecules in the asymmetric unit (could be 1000 to 2000 KD protein mass), the molecular replacement process was challenging. Different tetramers, dimers, and monomers of IKK2 were used as search models in programs PHASER, MOLREP and CNS without success. We surmised the problem to stem from a weak diffraction data, compounded with significant changes in inter-molecular or inter-domain organization of IKK1. A dimer of human IKK2 (PDB ID 4KIK) was rigid body refined based on the densities of cryoEM maps and further modified to different openings at the N-terminal KD-ULD portions (between 30-60 Å). With one of the dimers (52 Å opening) as a search model, we located six dimers in the asymmetric unit using MOLREP. These six dimers form two hexamers in the asymmetric unit with a solvent content of 68%. The orientation and position of individual dimers, or domains thereof, in this initial model were refined by rigid body refinement in CNS (cns_solve_1.3). The structure was further refined using energy minimization and simulated annealing with a maximum likelihood target function and a flat bulk-solvent correction using the CNS system. The model rebuilding was performed in 2FO-FC and FO-FC maps using Xtalview. Due to the lower resolution of our data, DEN-assisted refinement (Schroder et al., 2010) and NCS restrain were applied during the refinement procedure. DEN refinement dramatically improved geometries and R-factors of the structure; the R factor was 23.5% and free R factor was 27.9% for the final model. The detailed results of the refinement are included in Supplemental Table 1 .
Cryo-EM Data Acquisition.
Data were acquired over two separate sessions using the Leginon software (Suloway et al., 2005) installed on an FEI Titan Krios electron microscope operating at 300 kV, with a dose of 40 e-/Å 2 and an estimated underfocus ranging from 1.1-5.2 m (centered at 3.0  0.7 m). The dose was fractionated over 50 raw frames collected over 10-sec exposure time (200 ms per frame) on the Gatan K2 Summit direct detection device, with each frame receiving a dose of ~6.5 e -/pixel/sec. 2918 movies were collected and recorded at a nominal magnification of 22,500, corresponding to a pixel size of 1.31 Å at the specimen level. The individual frames were gain corrected, then aligned and summed using a GPU-enabled whole frame alignment program (Li et al., 2013) , and exposure-filtered (Grant and Grigorieff, 2015) .
Cryo-EM Image Analysis.
Pre-processing operations prior to the refinement of the final models were performed using the Appion package (Lander et al., 2009) and are conceptually identical to those previously described (Lyumkis et al., 2013a) . Briefly, particles were initially selected by hand from the aligned and summed micrographs to produce a ~500-particle stack, which was subjected to a round of 2D alignment and classification using CL2D (Sorzano et al., 2010) implemented within the Xmipp package (Sorzano et al., 2004) .
This produced templates were used to select more particles. IKK1 particle selections were further refined using these templates, from which 230,242 were used to create an initial raw particle stack after removing regions of the micrographs containing carbon and large areas of aggregation. 2D alignments and classifications were performed using the CL2D algorithm ( Figure 1B) , and an initial model was generated directly from the class averages using OptiMod (Lyumkis et al., 2013b ) ( Figure 1C) . Following iterative rounds of 2D alignment and classification, 109,820 particles remained for 3D refinement and classification. 3D classifications were initially performed within Relion (Scheres, 2012) , after which the parameters were converted for use in Frealign (Grigorieff, 2007) . The final classifications and refinements were performed in Frealign. Three conformational states were captured using a four-class classification, with the last class corresponding to particles that produced a low-resolution reconstruction (increasing this number to 5 or 6 classes did not increase the number of recovered conformational states). Although three conformational states were recovered during classification, it is likely these states are not discrete, and a continuum of movement about the central hinge exists, which is indicated by the relatively homogeneous distribution of particles within the classes (Supplemental Figure 3A , E, G and Supplemental Table 2 ).
During 2D alignment and classification, we noticed that a small percentage of particles apparently formed multiple dimers stacked side-by-side (Figures 1B, 2D ). After several rounds of sub-classification, it became apparent that this small percentage of particles actually corresponded to an oligomer of IKK1 dimers ( Figure 2D , right panel).
An ab initio initial model was again generated from the subset of particles using OptiMod, (Figure 2E ), which showed that the oligomer was clearly hexameric in nature. 3D
classifications and refinements were performed in a similar fashion as for the dimers.
Only one conformational state was identified (despite asking for the recovery of up to 5 classes), which was refined to ~5.9 Å resolution ( Figure 2F, Supplemental Figure 3I ).
IKK1 Dimer Model Building and Refinement from Cryo-EM Data.
Models of IKK1 dimers were built in a stepwise manner using Rosetta (DiMaio et al., 2015) for each of the three conformational states, independently. As a starting model, we used the structure of hIKK2 (PDB 4KIK) that was sequence-mapped to match hIKK1
(residues 14-660). First, the starting model was relaxed into density. We next independently refined and rebuilt each individual domain (SDD, ULD, and KD). Regions that were outside of EM density were deleted. 2000 models were generated in the first round for each domain using the 'hybridize' protocol in Rosetta, which rebuilds any missing regions (7-mer constructs were selected). Model-quality was assessed by energy scores and structural similarity. The five lowest energy models were selected for moving forward. In the second round of refinement, each of the three domains was seeded with the five top-scoring models from round 1, and 2000 models were again generated. The lowest energy models stitched together to form the full IKK1 monomer.
The full model for the dimer was refined with C2-symmetry imposition using the 'relax' protocol in Rosetta. Refinements were followed by manual model inspection (and rebuilding where necessary) in Coot (Emsley et al., 2010) . Several iterative rounds of refinement and inspection were performed, with the model being evaluated using MolProbity (Chen et al., 2010; Davis et al., 2007) at the end of each round. The last refinement cycles were performed using the real_space_refinement protocol in Phenix (Afonine et al., 2012) . Regions of the final model that did not correspond to density or exhibited extensive flexibility (primarily in the KD, which is resolved to a lower resolution)
were deleted.
Immunoprecipitation Followed by In Vitro Kinase Assay (IP-KA):
HA-tagged human IKK1 constructs were cloned into an in-house modified pEYFP 
Cellular Signaling Assays:
Cellular signaling assays were performed with different versions of MEF cells (wt, genetic knock outs, reconstituted). Cells were freshly plated and grown typically for ~12
hrs and treated with the stimuli when became 50-60% confluent with a dose as mentioned in the corresponding figures. Of note, in cases of longer time points (e.g., -LTR treatment), cells were treated with the stimuli at the same time (i.e., same confluency) and harvested at different times to follow the signaling kinetics. IKK1 levels in these experiments were monitored using an antibody that specifically recognizes IKK1
and not IKK2 (-IKK1, Imgenex). Whereas canonical signaling was monitored using an -IB antibody (SC-371, Santa Cruz Biotechnology), p100 processing in non-canonical signaling was monitored using an antibody against the N-terminal p52 portion of the molecule (-p52NR, kindly provided by Dr. N. Rice, NIH).
NIK:IKK Co-Immunoprecipitation (Co-IP) Assay:
HA-IKK1 (wt and mutants), HA-IKK2 and Myc-NIK constructs were overexpressed in HEK293T for 42-48 hrs. Expression levels of IKK-proteins were normalized earlier with respect to the amount of plasmid DNA required for each sample.
Varying amounts of HA-IKK expressing cell lysates were incubated with a fixed amount of Myc-NIK containing extract in presence of anti-Myc antibody for 4-6 hours in the cold room on a rotating cell-mixer. Each cell lysate was precleared in presence of Protein-G sepharose beads, before using in the Co-IP assay. 1mg of total protein (adjusted with the addition of total lysate from untransfected cells) was used in each reaction in a volume of 250 l. 1 l of anti-Myc monoclonal antibody (clone 9E10) was used per mg of total cell lysate. 10 l of Protein-G sepharose beads were added to the resulting mixture and incubated for another hour in cold on a rotating cell-mixer. Beads were washed with 500l of wash buffer for 3-4 times. Resulting co-immunoprecipitated complex was analyzed by immunoblotting.
Determination of Oligomeric Status of IKK1 in Cells by Size-Exclusion
Chromatography:
Size-exclusion chromatography was performed on S100 extracts prepared from indicated MEF or HEK293T cell lines. For preparation of S100 extract, MEF or HEK293T cells were grown to approximately 80% confluency in DMEM media containing 10 % BCS or FBS, respectively, and 1 % Penicillin-Streptomycin-Glutamine. Cells from two 150 mm plates were harvested by scraping with ice-cold PBS. Cells were spun at 1700 rpm (Eppendorf A-4-81) at 4 °C for 5 min. Pellet was gently resuspended in low ionic buffer (HEPES pH 7.9 10mM, KCl 10 mM and EDTA 0.1 mM) for 30 min on ice. NP40 was added to the resuspended cells to a final concentration of 0.1%. Cells were then lysed with dounce homogenizer (20-40 strokes) so that approximately 80% cells were ruptured. One fourth volume of 5X size-exclusion buffer (Tris pH 7.5 100 mM, EDTA 2.5 mM, NaCl 750 mM, Glycerol 50%, DTT 2 mM, NaF 20 mM, -Glycerophosphate 20 mM, SIGMA Protease Inhibitor Cocktail) was added to the suspended cells. The buffer containing ruptured cells was centrifuged for 10 min at 425 g to separate nuclei and intact cells. The supernatant was carefully isolated and centrifuged at 15700 rcf for 30 min at 4 °C. Two hundred microliter of clarified supernatant was loaded immediately to a equilibrated Superose 6 10/300GL GE Healthcare column.
